UK Life Sciences Future50 – Momentum in an evolving landscape

pwc Read more (pdf)

11 neuroscience biotech companies you should know about

Labiotech Read more

Is this mitochondria’s big moment?

Longevity Technology Read more

NRG Therapeutics: Restoring motor neuron function via mitochondria

BioCentury Read more (behind a paywall)

NRG raises $67M to test mitochondrial pore inhibitor in ALS

BioWorld Read more (behind a paywall)

A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria

Biopharma Dive Read more

UK’s NRG Powers Up With £50m For Promising Mitochondrial Therapy

SCRIP Read more (behind a paywall)

NRG raises $67 million for a small molecule for Parkinson’s and ALS

c&en Read more

Stevenage, UK based NRG Therapeutics raised a $67M series B today to advance its aim to restore mitochondrial function and slow the progression of neurodegenerative diseases like Parkinson’s and ALS

Biotech TV Watch more